Durect Corp Stock, NASDAQ:DRRX
10260 Bubb Road, Cupertino, California 95014-4166
United States of America
Number of Employees: 81
DURECT Corp. focuses in advancing novel and potentially lifesaving investigational therapies derived from its Epigenetic Regulator Program. Its pipeline is called DUR-928, an endogenous sulfated oxysterol and an epigenetic regulator. The company was founded by James E. Brown and Felix Theeuwes on February 6, 1998 and is headquartered in Cupertino, CA.